Home » Pharmaceuticals

The use of the genetically engineered drug denosumab in women with postmenopausal osteoporosis: a two-year observation in clinical practice

Rating
( 2 ratings, average 4.5 out of 5 )
Did you like the article? Share with friends:
You may also be interested
Table 3. Adverse events registered during rituximab treatment
Experience of using a biosimilar of a genetically engineered biological drug in patients with rheumatoid arthritis in real clinical practice
Tenoten for children
Use of the drug Tenoten in clinical practice
Vulvovaginal candidiasis. Application of Zalain in clinical practice
Katadolon - pain reliever
Application of a new analgesic Katadolon (flupirtine) in clinical practice
Use of a microdose contraceptive drug. Logest in the treatment of acne in women
Sonapax in clinical practice
Phenotropil: instructions for use and price
Experience of using Phenotropil in clinical practice
Possibilities of using adaptol in clinical practice
Pain and ketoprofen: the role of ketoprofen in clinical practice
Table 1. Bioavailability (absorption) of various organic forms of calcium within 2 hours after oral administration in the experiment [22]
Organic calcium salts: prospects for use in clinical practice
Nausea and vomiting in clinical practice (etiology, pathogenesis, prevention and treatment)
Incretin-based therapy. Experience of using Galvus and Galvus Met in Russian clinical practice: preliminary data
For any suggestions regarding the site: [email protected]
Для любых предложений по сайту: [email protected]